• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Glaukos

Glaukos posts Street-beating Q1 results

May 6, 2022 By Danielle Kirsh

Glaukos (NYSE:GKOS) this week posted first-quarter results that beat the overall consensus on Wall Street. The San Clemente, California-based company reported profits of $5.4 million, or 11¢ per share, on sales of $67.7 million for the three months ended March 31, for a sales loss of -0.42% compared with Q1 2021. Adjusted to exclude one-time items, […]

Filed Under: MassDevice Earnings Roundup, Optical/Ophthalmic, Wall Street Beat Tagged With: Glaukos

Glaukos rises on Street-beating Q4

February 23, 2022 By Sean Whooley

Glaukos (NYSE:GKOS) shares ticked up today on fourth-quarter results that beat the consensus forecast. The San Clemente, California-based eye disease treatment developer posted losses of $21.9 million, or losses per share of 47¢, on sales of $73.2 million for the three months ended Dec. 31, 2021, for a bottom-line slide deeper into the red on […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Implants, MassDevice Earnings Roundup, Optical/Ophthalmic, Wall Street Beat Tagged With: Glaukos

Glaukos announces executive leadership changes

February 8, 2022 By Danielle Kirsh

Glaukos this week announced several executive leadership changes that will take place on April 1. Joseph Gilliam is appointed as president and COO. He previously served as the CFO and SVP of corporate development for the San Clemente, California-based ophthalmic medtech and pharma company since 2017. Here are Glaukos’ new executive committee appointments: Chris Calcaterra […]

Filed Under: Business/Financial News, News Well, Optical/Ophthalmic Tagged With: Glaukos, Personnel Moves

These medtech companies care a lot about research

January 19, 2022 By Chris Newmarker

They’re making glaucoma-treating stents, tumor-treating fields, coin-sized CGMs and more. Discover the medtech companies that spend the most on research as a percentage of revenue. The list comes from our annual Big 100 report, which examines the world’s 100 largest medical device companies and ranks them by revenue. (Check out our full Big 100 report […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Cardiovascular, Diabetes, Featured, Neuromodulation/Neurostimulation, News Well, Oncology, Optical/Ophthalmic, Research & Development Tagged With: AtriCure Inc., Big 100, Dexcom, Glaukos, Inspire Medical Systems Inc., NovoCure

FDA clears Glaukos’ iPrime

January 7, 2022 By Sean Whooley

Glaukos (NYSE:GKOS) announced that it received FDA 510(k) clearance for its iPrime viscodelivery system. San Clemente, California-based Glaukos designed the Prime viscodelivery system as a sterile, single-use, minimally invasive device for delivering viscoelastic fluid during ophthalmic surgery. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: 510(k), Business/Financial News, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Optical/Ophthalmic, Regulatory/Compliance Tagged With: FDA, Glaukos

Glaukos announces licensing deal with Attillaps for pharmaceutical compounds

September 20, 2021 By Sean Whooley

Glaukos (NYSE:GKOS) announced today that it entered into a licensing agreement with Attillaps for its library of pharmaceutical compounds. San Clemente, California-based Glaukos was granted a global exclusive license to research, develop, manufacture and commercialize Attillaps’ proprietary library of investigational pharmaceutical compounds that target the eradication of Demodex mites — the root cause of Demodex blepharitis […]

Filed Under: Business/Financial News, Drug-Device Combinations, Optical/Ophthalmic, Pharmaceutical Tagged With: Attillaps, Glaukos

Ivantis to pay $60M in patent litigation settlement with Glaukos

September 15, 2021 By Sean Whooley

Glaukos (NYSE:GKOS) announced today that it entered into a settlement with Ivantis to terminate a three-year-old patent infringement lawsuit. San Clemente, California-based Glaukos’ patent infringement lawsuit, initiated on April 14, 2018, in the U.S. District Court for the Central District of California, Southern Division, concerned Ivantis’ Hydrus Microstent for reducing eye pressure in glaucoma patients. Get the full […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Implants, Optical/Ophthalmic, Stents Tagged With: Glaukos, Ivantis

Glaukos submits supplemental PMA application for iStent Infinite

September 3, 2021 By Sean Whooley

Glaukos (NYSE:GKOS) announced today that it submitted a supplemental premarket approval application to the FDA for its iStent Infinite system. San Clemente, California–based Glaukos designed the iStent Infinite trabecular micro-bypass system for use in a standalone procedure to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma uncontrolled by prior surgery or medical therapy. Get […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Implants, Optical/Ophthalmic, Pre-Market Approval (PMA), Regulatory/Compliance, Stents Tagged With: FDA, Glaukos

Glaukos beats The Street in Q2, grows sales 147%

August 6, 2021 By Danielle Kirsh

Glaukos (NYSE:GKOS) posted second-quarter results today that beat the overall consensus on Wall Street. The San Clemente, Calif.-based company reported losses of -$17.5 million, or -38¢ per share, on sales of $78.1 million for the three months ended June 30 for a sales growth of 147.46% compared with Q2 2020. Adjusted to exclude one-time items, earnings […]

Filed Under: MassDevice Earnings Roundup, Wall Street Beat Tagged With: Glaukos

The 18 most innovative medical devices of 2021

July 20, 2021 By Danielle Kirsh

The Galien Foundation today announced the nominees for most innovative medical devices for its 15th annual Prix Galien USA Awards. The foundation nominates devices, biotechnology and pharmaceutical products for its annual Prix Galien awards to highlight products designed to improve the human condition. “The Awards Committee is excited to introduce the nominees for the 2021 […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Cosmetic/Aesthetic, Dental, Diagnostics, Digital Health, Endoscopic, Featured, Imaging, Implants, Optical/Ophthalmic, Pain Management, Patient Monitoring, Pharmaceutical, Replacement Heart Valves, Respiratory, Stents, Structural Heart, Structural Heart, Urology Tagged With: Allergan, baylismedical, BD, Biotronik, Boston Scientific, Cala Health, cvrx, Edwards Lifesciences, endomag, Galien Foundation, Glaukos, humanoptics, Pear Therapeutics, Prix Galien USA, Pulmonx, Sonendo, tevapharmaceuticals

Glaukos wins Australian regulatory approval for MicroShunt

June 17, 2021 By Danielle Kirsh

Glaukos (NYSE:GKOS) recently announced that it received regulatory approval from Australia’s Therapeutic Goods Administration for its Preserflo MicroShunt. The San Clemente, Calif.–based company designed the MicroShunt to reduce intraocular pressure in the eyes of patients who have primary open-angle glaucoma where IOP remains uncontrollable or where glaucoma progression needs surgery. Get the full story on our […]

Filed Under: Implants Tagged With: Glaukos

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 7
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS